期刊文献+

C-反应蛋白与尿毒症维持性血液透析患者心血管并发症关系的探讨 被引量:2

The association among C-reactive protein and cardiovascular risk in uremic patients with undergoing maintenance hemodialysis
下载PDF
导出
摘要 目的探讨尿毒症维持性血液透析患者C-反应蛋白(C-reactive protein,CRP)与心血管并发症的关系。方法抽取32例尿毒症维持性血液透析患者透析前静脉血,检测血清中CRP、总胆固醇、三酰甘油、高密度脂蛋白胆固醇及低密度脂蛋白胆固醇含量,根据CRP水平分为正常组(CRP≤8mg/L)和升高组(CRP>8mg/L)。结果异常组总胆固醇(CHOL)高于正常组,统计学分析差异具有统计学意义(P<0.05),而三酰甘油(TG)、高密度脂蛋白胆固醇(HDL-C)及低密度脂蛋白胆固醇(LDL-C)差异无统计学意义(P>0.05)。尿毒症维持性血液透析患者血清CRP与CHOL正相关(P<0.05),与TG、HDL-C、LDL-C无相关关系(P>0.05)。结论尿毒症维持性血液透析患者血清CRP是炎症反应较好的预测指标,其对心血管并发症的预防和治疗有一定临床指导意义。 Objective To study association among C-reactive protein and cardiovascular risk in uremic patients with undergoing maintenance hemodialysis. Methods Thirty-two patients on maintenance hemodialysis due to uremia were studied. Blood samples were collected on the same day on hemodialysis at fast and the levels of blood-sermn CRP, total cholestesterol, triglyceride, high-density hpoprotein cholesterol and low-density lipoprotein cholesterol were determined. All patients were divided into normal group ( CRP ≤ 8mg/L) or abnormal group( CRP 〉 8mg/L). Results There were significant difference( P 〈 0.05 ) of serum CHOL between normal CRP patients and abnormal CRP patients. There were no significant difference( P 〉 0.05) of serum TG, HDL-C and LDL-C between normal CRP patients and abnormal CRP patients. Positive correlation was found between the levels of CRP and CHOL( P 〈 0.05 ). Negative correlation was found between the levels of CRP and TG, HDL- C and LDL-C ( P 〉 0.05 ). Conclusion CRP can be used as better markers of inflammation in patients on maintenance hemodialysis due to uremia which should be beneficial to prevent and treat the various cardiovascular complications of these patients.
作者 徐雁霞
出处 《四川医学》 CAS 2009年第2期209-210,共2页 Sichuan Medical Journal
关键词 C-反应蛋白 尿毒症 血液透析 心血管疾病 C-reactive protein uremia hemodialysis cardiovascular risk
  • 相关文献

参考文献10

  • 1Bergsrom J, Lindholm B. What are Ihe causes and consequences of the chronic inflammatory state in chronic dialysis patients[J]. Seminars in Dialysis, 2000,12 : 163.
  • 2Ridker PM, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events[J]. N Engl J Meal,2002,347(20): 1557 -1565.
  • 3Paul M, Ridker PM, MPH. High-sensitivity C-reactive protein potential adjunct for global risk assessment in the primary prevention of cardiovascular disease[J]. Circulation ,2001,103(104) : 1813 - 1818.
  • 4Danesh J, Whincup P, Walker M, et al. Low grade inflammation and coronary heart disease:prospective study and updated meta-analyses[ J]. British Medical Journal, 2000,321 (7255) : 199 - 204.
  • 5Rifai N, Ridker PM. High-sensitivity C-reactive protein: A novel and promising marker of coronary heart dlsease[J]. Clin Chem,2001,47(3) : 403 - 411.
  • 6鄢盛恺.超敏C反应蛋白测定在动脉粥样硬化疾病诊治中的应用[J].诊断学理论与实践,2002,1(4):267-269. 被引量:109
  • 7杨照勇,荣海钦.C反应蛋白与代谢综合征[J].国外医学(内分泌学分册),2004,24(3):173-175. 被引量:58
  • 8Rattazzi M, Puato M, Faggin E, et al. New markers of accelerated atherosclerosis in end-stage renal disease[J]. Review J Nephrol,2003,16 (1):11 -20.
  • 9Kim SB, Min WK, Lee SK, et al. Persistent elevation of C-reactive protein and ischemic heart disease in patients with continuous ambulatoty peritoneal dialysis[J]. Am J Kidney Dis,2002,39(2) :342 - 346.
  • 10Panichi V, Migliori M. C-reactive protein and interleukin-6 levels are related to renal function in predialytic chronic renal failure[J]. Nephron, 2002,91(4) :594 - 600.

二级参考文献37

  • 1[1]Ross R. Atherosclerosis-an inflammatory disease[J]. N Engl J Med, 1999, 340(2): 115-126.
  • 2[2]Ledue TB, Rifai N. High sensitivity immunoassays for C-reactive protein: promises and pitfalls[J]. Clin Chem Lab Med, 2001, 39(11):1171-1176.
  • 3[3]Whicher J, Rifai N, Biasucci LM. Markers of the acute phase response in cardiovascular disease: an update[J].Clin Chem Lab Med, 2001, 39(11):1054-1064.
  • 4[4]Rifai N, Ridker PM. High-sensitivity C-reactive protein:a novel and promising marker of coronary heart disease [J]. Clin Chem, 2001,47(3):403-411.
  • 5[5]Morley JJ, Kushner I. Serum C-reactive protein levels in disease[J]. Ann N Y Acad Sci, 1982,389:406-418.
  • 6[8]Rothkrantz-Kos S, Schmitz MP, Bekers O, et al. Highsensitivity C-reactive protein methods examined[J]. Clin Chem, 2002,48(2): 359-362.
  • 7[9]Ferreiros ER, Boissonnet CP, Pizarro R, et al. Independent prognostic value of elevated C-reactive protein in unstable angina [J]. Circulation, 1999,100 (19):1958-1963.
  • 8[10]Morrow DA, Rifai N, Antman EM, et al. C-Reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy[J]. J Am Coll Cardiol ,1998; 31(7): 1460 -1465.
  • 9[11]de Winter RJ, Bholasingh R, Lijmer JG, et al. Independent prognostic value of C-reactive protein and troponin I in patients with unstable angina or non-Q-wave myocardial infarction[J]. Cardiovasc Res, 1999,42 (1):240-245.
  • 10[12]Haverkate F, Thompson SG, Pyke SD, et al. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group [J]. Lancet ,1997, 349(9050): 462-466.

共引文献165

同被引文献18

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部